Trial | NCT04395716  Report issue

Title

A Study of ResCure™ to Treat COVID-19 Infection
A Phase I Study of ResCure™ to Treat COVID-19 Infection

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Withdrawn

  • Study Participants

    0
This is a Phase I open-label interventional study which will test the efficacy of ResCure™ in the treatment of patients with COVID-19 infection.
In this Phase I open-label interventional study we will test the efficacy of ResCure™ in the treatment of patients with COVID-19 infection. Patients being treated will have severe respiratory symptoms that are at or near requiring the patient be placed on a ventilator.
Study Started
Jan 31
2020
Anticipated
Primary Completion
Jun 30
2021
Anticipated
Study Completion
Nov 30
2021
Anticipated
Last Update
Apr 08
2021

Biological ResCure™

Patients will be treated with nebulized ResCure™

Treatment Group Experimental

This group will be treated with nebullized ResCure™ while hospitalized every 4 to 6 hours, depending on disease severity and ventilator status.

Criteria 

Inclusion Criteria:

Critically ill patients with SARS from COVID-19 infection on respirators OR
Patients with SARS from COVID-19 infection prior or after being placed on respirator
Male or female patients 18 years of age and older

Exclusion Criteria:

1. Patients less than 18 years of age
No Results Posted